Publication | Closed Access

Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial

Perinatal Hiv PreventionMedicineAntiviral Drug DevelopmentAntiviral TherapyResistance Mutation (Virology)VirologyPharmacotherapySingle-dose TenofovirViral ResistanceAntiviral DrugHivPharmacology